genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Myelodysplastic syndrome
Industry News
TetraLogic Retains Strategic Advisor, Lays Off Two-Thirds of Workforce
Cancer
Takeda, MacroGenics Launch Up to $1.6B Expansion of DART Collaboration
Cancer
Cancer Stem Cells Found by Backtracking Mutations in Human Patients
News
Array BioPharma President/CSO Resigns
News
Personalizing Leukemia Treatment
Cancer
Apogenix Raises €7.5M to Progress Glioblastoma Drug Through Phase II
Cancer
Apogenix Wins €2.3M to Develop Drug for Myelodysplastic Syndrome
Cancer
SymBio Inks Deal for Japanese and Korean Rights to Onconova’s Pivotal-Stage MDS Therapy
News
CytRx Sells Molecular Chaperone Assets to Orphazyme in Deal Worth $120M
Cancer
Cephalon Makes $231M Overall Bid to Acquire ChemGenex for NDA-Ready CML Drug
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
